Therefore, decreased immune abundance of CD8 + T cells and M1 macrophages (Fig. 6A), and increased that of M2 macrophages resulting from high CR risk all pointed toward unfavorable changes to the anti-cancer immune process. This evidence concerns the gene CD8A and cancer.